Requests that the FDA take administrative action to review the safety of uterine lavage (using an automated catheter and fluid recovery system) as a nonsurgical method of embryo extraction and to evaluate it as a safe, mechanical alternative to mifepristone for early embryo removal | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-3169

Requests that the FDA take administrative action to review the safety of uterine lavage (using an automated catheter and fluid recovery system) as a nonsurgical method of embryo extraction and to evaluate it as a safe, mechanical alternative to mifepristone for early embryo removal

Documents

Comments

Description

Open

Key Dates

Comment Period OpensMar 27, 2026

Documents

Type	Title	Posted	Comments	Status
Supporting Material	Attachment 2 - Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Luteum	Mar 27, 2026	--

Keywords

CDER

Citizen Petition

Requests that the FDA:

1. Initiate a formal safety review of uterine

lavage performed with the described single-use

12F flexible 3-lumen polyurethane catheter and

automated fluid recovery controller for

the purpose of embryo extraction.

Data from Regulations.gov